Terms: = Brain cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Prognosis
38 results:
1. The emerging role of fatty acid binding protein 7 (FABP7) in cancers.
George Warren W; Osborn M; Yates A; O'Sullivan SE
Drug Discov Today; 2024 May; 29(5):103980. PubMed ID: 38614160
[TBL] [Abstract] [Full Text] [Related]
2. Eosinophils induces glioblastoma cell suppression and apoptosis - Roles of GM-CSF and cysteinyl-leukotrienes.
Vieira BM; de São José VS; Niemeyer Filho PS; Moura-Neto V
Int Immunopharmacol; 2023 Oct; 123():110729. PubMed ID: 37536182
[TBL] [Abstract] [Full Text] [Related]
3. Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase.
Gao T; Huang J; Yin H; Huang J; Xie J; Zhou T; Fan W; Yang X; Gao G; Li Z
Cell Death Dis; 2023 May; 14(5):316. PubMed ID: 37160920
[TBL] [Abstract] [Full Text] [Related]
4. FAIM2 is correlated with metastasis of medulloblastoma through bioinformatics analysis.
Zhou X; Zhao H
Medicine (Baltimore); 2023 Apr; 102(16):e33591. PubMed ID: 37083768
[TBL] [Abstract] [Full Text] [Related]
5. Establishment and Validation of a Machine Learning Prediction Model Based on Big Data for Predicting the Risk of Bone Metastasis in Renal Cell Carcinoma Patients.
Xu C; Liu W; Yin C; Li W; Liu J; Sheng W; Tang H; Li W; Zhang Q
Comput Math Methods Med; 2022; 2022():5676570. PubMed ID: 36226243
[TBL] [Abstract] [Full Text] [Related]
6. An integrative multi-omics analysis based on liquid-liquid phase separation delineates distinct subtypes of lower-grade glioma and identifies a prognostic signature.
Zheng J; Wu Z; Qiu Y; Wang X; Jiang X
J Transl Med; 2022 Jan; 20(1):55. PubMed ID: 35093128
[TBL] [Abstract] [Full Text] [Related]
7. Association of radiation dose intensity with overall survival in patients with distant metastases.
Kao J; Farrugia MK; Frontario S; Zucker A; Copel E; Loscalzo J; Sangal A; Darakchiev B; Singh A; Missios S
Cancer Med; 2021 Nov; 10(22):7934-7942. PubMed ID: 34595844
[TBL] [Abstract] [Full Text] [Related]
8. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.
Yamamura J; Kamigaki S; Fujita J; Osato H; Manabe H; Tanaka Y; Shinzaki W; Hashimoto Y; Komoike Y
BMC Cancer; 2021 Apr; 21(1):476. PubMed ID: 33926418
[TBL] [Abstract] [Full Text] [Related]
9. C
He XY; Xiong LL; Xia QJ; Wang YY; Zhao XM; Du RL; Huang J; He XQ; Jia-Liu ; Wang TH
Biomed Res Int; 2019; 2019():6821219. PubMed ID: 30915356
[TBL] [Abstract] [Full Text] [Related]
10. The SIAH1-HIPK2-p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death.
He Y; Roos WP; Wu Q; Hofmann TG; Kaina B
Mol Cancer Res; 2019 May; 17(5):1129-1141. PubMed ID: 30796178
[TBL] [Abstract] [Full Text] [Related]
11. Role of FABP7 in tumor cell signaling.
Kagawa Y; Umaru BA; Ariful I; Shil SK; Miyazaki H; Yamamoto Y; Ogata M; Owada Y
Adv Biol Regul; 2019 Jan; 71():206-218. PubMed ID: 30245263
[TBL] [Abstract] [Full Text] [Related]
12. RBM17 controls apoptosis and proliferation to promote Glioma progression.
Lu J; Li Q; Cai L; Zhu Z; Guan J; Wang C; Xia J; Xia L; Wen M; Zheng W; Su Z; Wang C
Biochem Biophys Res Commun; 2018 Oct; 505(1):20-28. PubMed ID: 30227940
[TBL] [Abstract] [Full Text] [Related]
13. Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centres.
Grant M; Haydon A; Au L; Wilkins S; Oliva K; Segelov E; Antill Y; Carne P; Ranchod P; Polglase A; Farmer C; Chin M; Wale R; Simpson P; Bell S; Skinner S; McMurrick P; Shapiro J
Int J Surg; 2018 Mar; 51():71-75. PubMed ID: 29367039
[TBL] [Abstract] [Full Text] [Related]
14. Survival and prognostic factors for patients with melanoma brain metastases in the era of modern systemic therapy.
Tio M; Wang X; Carlino MS; Shivalingam B; Fogarty GB; Guminski AD; Lo S; Hong AM; Menzies AM; Long GV
Pigment Cell Melanoma Res; 2018 Jul; 31(4):509-515. PubMed ID: 29277979
[TBL] [Abstract] [Full Text] [Related]
15. Treatment strategies in recurrent esophageal or junctional cancer.
Butter R; Lagarde SM; van Oijen MGH; Anderegg MCJ; Gisbertz SS; Meijer SL; Hulshof MCCM; Bergman JJGHM; van Berge Henegouwen MI; van Laarhoven HWM
Dis Esophagus; 2017 Sep; 30(9):1-9. PubMed ID: 28859371
[TBL] [Abstract] [Full Text] [Related]
16. Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing.
Riccadonna C; Yacoub Maroun C; Vuillefroy de Silly R; Boehler M; Calvo Tardón M; Jueliger S; Taverna P; Barba L; Marinari E; Pellegatta S; Bassoy EY; Martinvalet D; Dietrich PY; Walker PR
PLoS One; 2016; 11(8):e0162105. PubMed ID: 27579489
[TBL] [Abstract] [Full Text] [Related]
17. Saponin 6 derived from Anemone taipaiensis induces U87 human malignant glioblastoma cell apoptosis via regulation of fas and Bcl‑2 family proteins.
Ji CC; Tang HF; Hu YY; Zhang Y; Zheng MH; Qin HY; Li SZ; Wang XY; Fei Z; Cheng G
Mol Med Rep; 2016 Jul; 14(1):380-6. PubMed ID: 27175997
[TBL] [Abstract] [Full Text] [Related]
18. cd95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells.
Drachsler M; Kleber S; Mateos A; Volk K; Mohr N; Chen S; Cirovic B; Tüttenberg J; Gieffers C; Sykora J; Wirtz CR; Mueller W; Synowitz M; Martin-Villalba A
Cell Death Dis; 2016 Apr; 7(4):e2209. PubMed ID: 27124583
[TBL] [Abstract] [Full Text] [Related]
19. fas-associated protein with death domain (FADD) regulates autophagy through promoting the expression of Ras homolog enriched in brain (Rheb) in human breast adenocarcinoma cells.
He L; Ren Y; Zheng Q; Wang L; Lai Y; Guan S; Zhang X; Zhang R; Wang J; Chen D; Yang Y; Zhuang H; Cheng W; Zhang J; Hua ZC
Oncotarget; 2016 Apr; 7(17):24572-84. PubMed ID: 27013580
[TBL] [Abstract] [Full Text] [Related]
20. IDH1/2 mutation status combined with Ki-67 labeling index defines distinct prognostic groups in glioma.
Zeng A; Hu Q; Liu Y; Wang Z; Cui X; Li R; Yan W; You Y
Oncotarget; 2015 Oct; 6(30):30232-8. PubMed ID: 26338964
[TBL] [Abstract] [Full Text] [Related]
[Next]
